MedPath

Effect of a Soluble Fibre Blend and Medium Chain Triglycerides on Body Composition and Cardiometabolic Risk Factors

Phase 2
Completed
Conditions
People Who Are Overweight or Obesity
Interventions
Dietary Supplement: cellulose and soybean oil
Dietary Supplement: soluble fibre complex and medium chain triglycerides
Registration Number
NCT00644098
Lead Sponsor
Canadian Center for Functional Medicine
Brief Summary

The purpose of this study is to investigate whether the addition of capsules containing soluble fibre complex emulsified with medium chain triglycerides and taken before with meals will lead to a significant amount of weight loss, reduced glycemic volatility and diminished cardio metabolic risk factors in overweight and obese individuals when compared to a placebo control.

We believe that those participants taking 3-6 capsules per day of the treatment capsules over a 14 week period will loose a significant amount of weight compared to the placebo group.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
138
Inclusion Criteria
  • BMI 27 - 35 kg/m2
Exclusion Criteria

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Placebocellulose and soybean oilcellulose and soybean oil
Interventionsoluble fibre complex and medium chain triglyceridessoluble fibre complex and medium chain triglycerides
Primary Outcome Measures
NameTimeMethod
weight lossbaseline, biweekly and final visit
Secondary Outcome Measures
NameTimeMethod
glycemic volatility and cardio metabolic risk factorsbaseline and final visit

Trial Locations

Locations (1)

Canadian Center for Functional Medicine

🇨🇦

Coquitlam, British Columbia, Canada

© Copyright 2025. All Rights Reserved by MedPath